Immunovant
Lesa Valentine is Vice President, Quality at Immunovant. Prior to joining Immunovant Lesa served as the Head of Global Quality at SanBio Inc, where she advanced the Quality Management System in support of a regenerative cell therapy product. Her background includes executive quality roles where she developed and implemented global systems and processes, assuring compliance and strategic risk mitigation across both development and commercial products for organizations such as Aimmune, Exelixis Genentech and Novartis.
Lesa earned a B.S. in Microbiology from University of Wyoming and is a member of The Parenteral Drug Association (PDA) and The Society of Quality Assurance (SQA).
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.